[Experiences with drug therapy in association with ischaemic vascular disease of the fundus oculi (author's transl)].
The action of Thilocombin was tested on various eye conditions classified in groups. Common to all six groups was the presence of ischaemic vascular disease with reduciton of central visual acuity. The results of long term treatment with Thilocombin were significant: in almost 60% of cases a lasting improvement of function could be achieved. In the remainder of cases worsening of the loss of vision could usually be arrested.
D000328:Adult; D000368:Aged; D004338:Drug Combinations; D005654:Fundus Oculi; D005901:Glaucoma / Q000188:drug therapy; D006535:Heptaminol / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007511:Ischemia / Q000188:drug therapy*; D008875:Middle Aged; D009540:Nicotinyl Alcohol / Q000494:pharmacology / Q000627:therapeutic use; D012164:Retinal Diseases / Q000188:drug therapy*; D012171:Retinal Vessels / Q000187:drug effects*; D013806:Theophylline / Q000494:pharmacology / Q000627:therapeutic use; D014792:Visual Acuity / Q000187:drug effects
D004338:Drug Combinations; D006535:Heptaminol; D009540:Nicotinyl Alcohol; D013806:Theophylline
Erfahrungen mit medikamentöser Therapie bei Durchblutungsstörungen des Augenhintergrundes.